AbCellera Biologics, Inc. (ABCL)
13.78
+0.04
(+0.29%)
USD |
NASDAQ |
Oct 05, 16:00
13.89
+0.11
(+0.80%)
After-Hours: 07:20
AbCellera Biologics Market Cap : 4.223B for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 05, 2026 | 4.223B |
| October 02, 2026 | 4.211B |
| October 01, 2026 | 4.263B |
| September 30, 2026 | 4.471B |
| September 29, 2026 | 4.542B |
| September 28, 2026 | 4.266B |
| September 25, 2026 | 3.892B |
| September 24, 2026 | 3.877B |
| September 23, 2026 | 3.773B |
| September 22, 2026 | 3.877B |
| September 21, 2026 | 3.880B |
| September 18, 2026 | 3.871B |
| September 17, 2026 | 3.901B |
| September 16, 2026 | 3.577B |
| September 15, 2026 | 3.497B |
| September 14, 2026 | 3.423B |
| September 11, 2026 | 3.337B |
| September 10, 2026 | 3.206B |
| September 09, 2026 | 3.386B |
| September 08, 2026 | 3.506B |
| September 04, 2026 | 3.503B |
| September 03, 2026 | 3.546B |
| September 02, 2026 | 3.481B |
| September 01, 2026 | 3.457B |
| August 31, 2026 | 3.518B |
| Date | Value |
|---|---|
| August 28, 2026 | 3.478B |
| August 27, 2026 | 3.800B |
| August 26, 2026 | 3.751B |
| August 25, 2026 | 3.831B |
| August 24, 2026 | 3.252B |
| August 21, 2026 | 3.469B |
| August 20, 2026 | 3.546B |
| August 19, 2026 | 3.681B |
| August 18, 2026 | 3.408B |
| August 17, 2026 | 3.432B |
| August 14, 2026 | 3.488B |
| August 13, 2026 | 3.362B |
| August 12, 2026 | 3.173B |
| August 11, 2026 | 2.991B |
| August 10, 2026 | 2.862B |
| August 07, 2026 | 2.124B |
| August 06, 2026 | 2.001B |
| August 05, 2026 | 1.814B |
| August 04, 2026 | 1.866B |
| August 03, 2026 | 1.787B |
| July 31, 2026 | 1.736B |
| July 30, 2026 | 1.729B |
| July 29, 2026 | 1.638B |
| July 28, 2026 | 1.608B |
| July 27, 2026 | 1.596B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| MindWalk Holdings Corp. | 70.02M |
| Repligen Corp. | 10.69B |
| Bio-Techne Corp. | 11.33B |
| Aurinia Pharmaceuticals, Inc. | 2.089B |
| BioLife Solutions, Inc. | 1.888B |
Market Cap Related Metrics
| PS Ratio | 62.89 |
| Price to Book Value | 4.713 |
| Price | 13.78 |
| Earnings Yield | -3.95% |